Seguir
John Baber
John Baber
General Surgery Resident, University of California Los Angeles
Dirección de correo verificada de mednet.ucla.edu
Título
Citado por
Citado por
Año
Matrix metalloproteinases in liver injury, repair and fibrosis
S Duarte, J Baber, T Fujii, AJ Coito
Matrix Biology 44, 147-156, 2015
4852015
Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis
VG Agopian, A Dhillon, J Baber, FM Kaldas, A Zarrinpar, DG Farmer, ...
American journal of transplantation 14 (7), 1638-1647, 2014
542014
The effect of HLA mismatch on highly sensitized renal allograft recipients
AS Paramesh, R Zhang, J Baber, CL Yau, DP Slakey, MT Killackey, ...
Clinical transplantation 24 (6), E247-E252, 2010
322010
A 20-year experience with liver transplantation for polycystic liver disease: does previous palliative surgical intervention affect outcomes?
JT Baber, JR Hiatt, RW Busuttil, VG Agopian
Journal of the American College of Surgeons 219 (4), 695-703, 2014
262014
Matrix Metalloproteinase-9 in Human Orthotopic Liver Transplant Biopsies.
S Duarte, N Datta, J Baber, R Busuttil, A Zarrinpar, A Coito
AMERICAN JOURNAL OF TRANSPLANTATION 16, 378-378, 2016
2016
ÔØ Å ÒÙ× Ö ÔØ
S Duarte, J Baber, T Fujii, AJ Coito
2015
Evaluating the Effects of Earlier Palliative Surgical Interventions on Post-Liver Transplant: In Reply to Zamora-Valdés and colleagues
JT Baber, JR Hiatt, RW Busuttil, VG Agopian
Journal of the American College of Surgeons 219 (6), 1192-1193, 2014
2014
Matrix Metalloproteinase-9 Inhibition Sheltered the Hepatocyte Growth Factor Receptor, c-Met, From Proteolytic Degradation in Marginal Steatotic Livers After Ischemia and …
H Kato, S Duarte, J Baber, S Isaji, R Busuttil, A Coito
Transplantation 98, 293, 2014
2014
Tenascin-C: A Crucial Proinflammatory Mediator in Macrosteatotic Liver Ischemia and Reperfusion Injury.: Abstract# A89
H Kato, S Duarte, J Baber, R Busuttil, A Coito
Transplantation 98, 291, 2014
2014
Matrix Metalloproteinase-12 Cleaves Tenascin-C and Mediates Early Hepatic Ischemia-Reperfusion Injury.: Abstract# 2225
J Baber, S Duarte, H Kato, R Busuttil, A Coito
Transplantation 98, 41, 2014
2014
Matrix Metalloproteinase-12 Is a Novel Mediator of Hepatic Ischemia-Reperfusion Injury.: Abstract# P-12
JT Baber, S Duarte, H Kato, RW Busuttil, AJ Coito
Liver Transplantation 19, S136, 2013
2013
Matrix Metalloproteinase-9 Deficiency Enhances Regeneration of Marginal Steatotic Livers after Ischemia and Reperfusion Injury.: Abstract# P-216
H Kato, S Duarte, J Baber, RW Busuttil, AJ Coito
Liver Transplantation 19, S196, 2013
2013
Liver Transplantation for Polycystic Liver Disease: A 20-Year Experience
J Baber, V Agopian, J Hiatt, R Busuttil
AMERICAN JOURNAL OF TRANSPLANTATION 13, 223-223, 2013
2013
Liver Transplantation (LT) in Patients Receiving Renal Replacement Therapy (RRT): Predicting Renal Recovery and Post-Transplant Futility
V Agopian, J Baber, A Dhillon, H Petrowsky, A Zarrinpar, F Kaldas, ...
AMERICAN JOURNAL OF TRANSPLANTATION 13, 170-170, 2013
2013
Matrix Metalloproteinase-9 Deficiency Enhances Regeneration of Marginal Steatotic Livers after Ischemia and Reperfusion Injury.
H Kato, S Duarte, J Baber, R Busuttil, A Coito
AMERICAN JOURNAL OF TRANSPLANTATION 13, 491-491, 2013
2013
Rejection Is the Most Significant Factor Affecting Graft Survival among Highly Sensitized Transplant Recipients.
AS Paramesh, R Zhang, SS Florman, MT Killackey, DP Slakey
AMERICAN JOURNAL OF TRANSPLANTATION 10, 397-397, 2010
2010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–16